ATE31022T1 - Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten. - Google Patents
Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.Info
- Publication number
- ATE31022T1 ATE31022T1 AT84850189T AT84850189T ATE31022T1 AT E31022 T1 ATE31022 T1 AT E31022T1 AT 84850189 T AT84850189 T AT 84850189T AT 84850189 T AT84850189 T AT 84850189T AT E31022 T1 ATE31022 T1 AT E31022T1
- Authority
- AT
- Austria
- Prior art keywords
- azo
- bis
- salicylic acid
- treatment
- medication
- Prior art date
Links
- ITHFNJCQUCSZHH-UHFFFAOYSA-N 4-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC=C1N=NC1=CC=C(O)C(C(O)=O)=C1 ITHFNJCQUCSZHH-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 208000028774 intestinal disease Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 2
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 2
- 210000000936 intestine Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229960004889 salicylic acid Drugs 0.000 abstract 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8303399A SE8303399D0 (sv) | 1983-06-15 | 1983-06-15 | Azo-bis-salicyl syra och salt derav, deras farmaceutiska beredning samt framstellning av syran |
| EP84850189A EP0133423B1 (de) | 1983-06-15 | 1984-06-15 | Verwendung von 4,5'-Azo-bis-Salicylsäure zur Herstellung eines Arzneimittels zur Behandlung entzündlicher Darmkrankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE31022T1 true ATE31022T1 (de) | 1987-12-15 |
Family
ID=20351605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84850189T ATE31022T1 (de) | 1983-06-15 | 1984-06-15 | Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4591584A (de) |
| EP (2) | EP0133423B1 (de) |
| JP (1) | JPS60501561A (de) |
| AT (1) | ATE31022T1 (de) |
| DE (1) | DE3467705D1 (de) |
| SE (1) | SE8303399D0 (de) |
| WO (1) | WO1985000013A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57500432A (de) * | 1980-03-20 | 1982-03-11 | ||
| US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
| AU8531101A (en) | 2000-08-29 | 2002-03-13 | Nobex Corp | Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
| US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| US7737133B2 (en) | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
| US7825106B2 (en) | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
| ES2565848T3 (es) | 2004-07-07 | 2016-04-07 | Biocon Limited | Síntesis de compuestos inmunorreguladores unidos por grupos azoicos |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1157169A (en) * | 1914-11-03 | 1915-10-19 | Geigy Ag J R | Mordant-dyeing azo dye. |
| US1824914A (en) * | 1928-03-15 | 1931-09-29 | Cie Nat Matieres Colorantes | Manufacture of chromed complexes of azo and ortho-hydroxy-azo dyestuffs |
| US2690438A (en) * | 1950-10-18 | 1954-09-28 | Hoechst Ag | Azo-dyestuffs |
| SE8002321L (sv) * | 1980-03-26 | 1981-09-27 | Pharmacia Ab | Sett och mellanprodukter for framstellning av bensoesyraderivat |
| SE8002322L (sv) * | 1980-03-26 | 1981-09-27 | Pharmacia Ab | Medel for behandling av inflammatoriska tarmsjukdomar |
| DE3027013A1 (de) * | 1980-07-17 | 1982-02-18 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin | Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln |
| US4312806A (en) * | 1981-03-02 | 1982-01-26 | G. D. Searle & Co. | Method and compounds for treating inflammatory bowel disease |
-
1983
- 1983-06-15 SE SE8303399A patent/SE8303399D0/xx unknown
-
1984
- 1984-06-15 DE DE8484850189T patent/DE3467705D1/de not_active Expired
- 1984-06-15 EP EP84850189A patent/EP0133423B1/de not_active Expired
- 1984-06-15 JP JP59502534A patent/JPS60501561A/ja active Pending
- 1984-06-15 US US06/709,032 patent/US4591584A/en not_active Expired - Fee Related
- 1984-06-15 AT AT84850189T patent/ATE31022T1/de not_active IP Right Cessation
- 1984-06-15 WO PCT/SE1984/000226 patent/WO1985000013A1/en not_active Ceased
- 1984-06-15 EP EP84902548A patent/EP0145777A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60501561A (ja) | 1985-09-19 |
| DE3467705D1 (en) | 1988-01-07 |
| US4591584A (en) | 1986-05-27 |
| EP0145777A1 (de) | 1985-06-26 |
| EP0133423A1 (de) | 1985-02-20 |
| WO1985000013A1 (en) | 1985-01-03 |
| EP0133423B1 (de) | 1987-11-25 |
| SE8303399D0 (sv) | 1983-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69625906D1 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| ES538807A0 (es) | Un procedimiento para la produccion de un complejo covalentemente unido de inhibidor de alfa-1-proteinasas con un polimero soluble en agua. | |
| IE870194L (en) | Use of lithium compounds in senile dementia | |
| MA19639A1 (fr) | Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives | |
| DE69121561D1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
| ATE123944T1 (de) | Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen. | |
| SE8107292L (sv) | 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav | |
| JPS54160740A (en) | Anti-fibrotic agent | |
| DE3873578D1 (de) | Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| ATE31022T1 (de) | Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten. | |
| DE3462894D1 (de) | 3-indolecarboxamide compounds | |
| ATE135573T1 (de) | Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten | |
| EP0354568A3 (de) | Catechol-Derivate | |
| DE3776561D1 (de) | Verwendung von petasites-extrakten zur herstellung eines arzneimittels zur behandlung von gastrointestinalen erkrankungen. | |
| DE69207479D1 (de) | Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen | |
| ATE40687T1 (de) | Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| DE69428797D1 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
| SE8303400D0 (sv) | Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning | |
| ZA872863B (en) | 1,4-dihydropyridine derivatives,process for their preparation and medicaments containing these compounds | |
| DE3674323D1 (de) | 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung. | |
| ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
| DE3887005D1 (de) | Mittel zur Behandlung von Nierenbeschwerden. | |
| ATE73326T1 (de) | Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |